Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer

BMC Medical Genetics

Table 2 The correlation between the expression of miR-101-3p and the baseline information of patients with gastric cancer (GC)

Index	Total cases	miR-101-3p expression		P-value
Index	Total cases	High	low	P-value
Age				0.3722
< 60 years	32	18	14
≥ 60 years	54	25	29
Sex				0.8123
Male	61	30	31
Female	25	13	12
Differentiation				0.2788
Middle/high	39	22	17
Low	47	21	26
Infiltration				0.0299*
Intramucosal	48	29	19
Submucosal	38	14	24
H. pylori infection				0.3864
H. Pylori (−)	47	21	26
H. Pylori (+)	39	22	17
Histological type				0.1600
Adenocarcinoma	60	26	34
Mucinous carcinoma	3	1	2
Signet ring cell carcinoma	8	5	3

Notes: High or low expression was defined according to the median expression of miR-101-3p. Qualitative data were expressed as number, and the difference was determined by X2 test. *, P < 0.05

ISSN: 1471-2350